Literature DB >> 3733374

In vitro chemosensitivity testing of human neuroblastoma cell lines in soft agar: a tumor-specific drug screening model.

M F Sarosdy, S L Schneider, B J Forseth, P M Zeltzer.   

Abstract

Tumor-specific screening of investigational anticancer drugs is a new approach to cytotoxic drug screening. A tumor-specific drug screening model has been designed using established human neuroblastoma cell lines. In vitro drug sensitivity was studied using a modification of the human tumor stem cell assay. Eleven cell lines were tested initially for colony formation in soft agar. Four cell lines formed only small cell clusters, while three cell lines formed colonies at a very low rate. The four remaining lines formed colonies with satisfactory efficiency. These cell lines were exposed to three concentrations each of cis-platinum, vincristine, doxorubicin, L-phenylalanine mustard, and ethidium chloride and suspended in soft agar. Colony formation was tabulated and sensitivities determined for each cell line. A heterogeneous pattern of in vitro sensitivity was observed. Limitations and pitfalls as well as potential advantages of using such a tumor-specific drug screening system are discussed.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3733374     DOI: 10.1007/bf00194592

Source DB:  PubMed          Journal:  Invest New Drugs        ISSN: 0167-6997            Impact factor:   3.850


  10 in total

1.  Onco-neural antigen: a new neural differentiation antigen expressed by neuroblastoma, oat cell carcinoma, Wilms' tumor, and sarcoma cells.

Authors:  R C Seeger; P M Zeltzer; S A Rayner
Journal:  J Immunol       Date:  1979-04       Impact factor: 5.422

2.  Morphology and growth, tumorigenicity, and cytogenetics of human neuroblastoma cells in continuous culture.

Authors:  J L Biedler; L Helson; B A Spengler
Journal:  Cancer Res       Date:  1973-11       Impact factor: 12.701

3.  Definition of a continuous human cell line derived from neuroblastoma.

Authors:  J J Tumilowicz; W W Nichols; J J Cholon; A E Greene
Journal:  Cancer Res       Date:  1970-08       Impact factor: 12.701

4.  In vitro evaluation of anticancer drugs with the human tumor stem cell assay.

Authors:  S E Salmon; D D Von Hoff
Journal:  Semin Oncol       Date:  1981-12       Impact factor: 4.929

5.  Evaluation of a "nude" mouse-human tumor panel as a predictive secondary screen for cancer chemotherapeutic agents.

Authors:  R E Bellet; V Danna; M J Mastrangelo; D Berd
Journal:  J Natl Cancer Inst       Date:  1979-11       Impact factor: 13.506

6.  Neuronal properties of neuroectodermal tumors in vitro.

Authors:  H R Schlesinger; L Rorke; R Jamieson; K Hummeler
Journal:  Cancer Res       Date:  1981-07       Impact factor: 12.701

7.  Activity of mitoxantrone in a human tumor cloning system.

Authors:  D D Von Hoff; C A Coltman; B Forseth
Journal:  Cancer Res       Date:  1981-05       Impact factor: 12.701

8.  Primary bioassay of human tumor stem cells.

Authors:  A W Hamburger; S E Salmon
Journal:  Science       Date:  1977-07-29       Impact factor: 47.728

9.  Association between human tumor colony-forming assay results and response of an individual patient's tumor to chemotherapy.

Authors:  D D Von Hoff; J Casper; E Bradley; J Sandbach; D Jones; R Makuch
Journal:  Am J Med       Date:  1981-05       Impact factor: 4.965

10.  Morphology, growth, chromosomal pattern and fibrinolytic activity of two new human neuroblastoma cell lines.

Authors:  R C Seeger; S A Rayner; A Banerjee; H Chung; W E Laug; H B Neustein; W F Benedict
Journal:  Cancer Res       Date:  1977-05       Impact factor: 12.701

  10 in total
  1 in total

1.  Use of human neuroblastoma continuous cell lines for in vitro drug sensitivity screening.

Authors:  B T Hill; R D Whelan; L K Hosking
Journal:  Invest New Drugs       Date:  1988-04       Impact factor: 3.850

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.